Skip to content

Depression: all studies

Page 891 of 1,034: studies 8,901 to 8,910 of 10,336, newest first. Back to the depression overview

Research

Changes in default-mode network activity and functional connectivity as an indicator of psychedelic-assisted psychotherapy effectiveness

Neuropsychiatria i Neuropsychologia 2018 Anastasia Ruban, Aleksandra Kołodziej 20 citations

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Ruban A, Kołodziej A. Changes in default-mode network activity and functional connectivity as an indicator of psychedelic-assisted psychotherapy effectiveness. Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology. 2018;13(3):91-97. doi:10.5114/nan.2018.81249. APA Ruban, A., & Kołodziej, A....

DOI: 10.5114/nan.2018.81249 (opens in new tab) Default mode network Neuropsychiatry Neuropsychology Functional connectivity

Therapeutic Applications of Classic Hallucinogens.

Current Topics in Behavioral Neurosciences 2018 Michael P. Bogenschutz, Stephen Ross 84 citations

This chapter reviews what is known about the therapeutic uses of the serotonergic or classic hallucinogens, i.e., psychoactive drugs such as LSD and psilocybin that exert their effects primarily through agonist activity at serotonin 2A (5HT2A) receptors. Following a review of the history of human use and scientific study of these drugs, the data from clinical research are summarized, including...

DOI: 10.1007/7854_2016_464 (opens in new tab) Psychological therapy Behavioral health solutions Mental healthcare Emerging therapies +9

Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study.

The American Journal of Drug and Alcohol Abuse 2018 Geoffrey E Noller, Chris M Frampton, Berra Yazar-Klosinski 150 citations

The psychoactive indole alkaloid ibogaine has been associated with encouraging treatment outcomes for opioid dependence. The legal status of ibogaine in New Zealand provides a unique opportunity to evaluate durability of treatment outcomes. To examine longitudinal treatment effects over a 12-month period among individuals receiving legal ibogaine treatment for opioid dependence. This...

DOI: 10.1080/00952990.2017.1310218 (opens in new tab) Full text (opens in new tab) Legal availability Opioid dependence Opioid detoxification Psychedelics +4

Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.

Current Topics in Behavioral Neurosciences 2018 Frederick S. Barrett, Roland R. Griffiths 268 citations

This chapter begins with a brief review of descriptions and definitions of mystical-type experiences and the historical connection between classic hallucinogens and mystical experiences. The chapter then explores the empirical literature on experiences with classic hallucinogens in which claims about mystical or religious experiences have been made. A psychometrically validated questionnaire is...

DOI: 10.1007/7854_2017_474 (opens in new tab) Full text (opens in new tab) These substances Specific compounds Substance use Mystical states +8

A Brief Review of Chemistry and Pharmacology of Lysergic Acid Diethylamide

December 30, 2017 S. Jadhav, Trupti Ghatage, A. M. Thanekar

Lysergic acid diethylamide (LSD), is a classical hallucinogen, discovered accidentally in the middle century. It is a psychedelic drug used to treat drug abuse as it shows limited efficacy, leaving severe and persistent effects in treated patients. Preliminary studies in animals and clinical trials suggest that lysergic acid diethylamide may have anti-depressive, anxiolytic, hallucinogenic and...

Is Metabolism of (R)-Ketamine Essential for the Antidepressant Effects?

The International Journal of Neuropsychopharmacology December 23, 2017 Shigeyuki Chaki 17 citations

Major depressive disorder (MDD) affects approximately 10% to 20% of the US population (Kessler et al. , 2005); thus, the economic burden of MDD is immense. Currently, selective serotonin reuptake inhibitors and serotonin- and noradrenaline-reuptake inhibitors are widely prescribed for patients with MDD as first-line treatments. However, these medications have several drawbacks; approximately...

Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine

The International Journal of Neuropsychopharmacology December 22, 2017 K. Fukumoto, M. Iijima, Takeo Funakoshi et al.

Abstract Background We previously reported that serotonergic transmission plays an important role in antidepressant effects of ketamine. However, detailed mechanisms have not been elucidated. Among the serotonin receptor subtypes, the serotonin1A receptor in the medial prefrontal cortex has an important role in depression. Here, we investigated the role of the medial prefrontal cortex...

Cannabinoid Modulation of the Stressed Hippocampus.

Frontiers in Molecular Neuroscience December 19, 2017 Franciele F Scarante, Carla Vila-Verde, Vinícius L Detoni et al.

Exposure to stressful situations is one of the risk factors for the precipitation of several psychiatric disorders, including Major Depressive Disorder, Posttraumatic Stress Disorder and Schizophrenia. The hippocampal formation is a forebrain structure highly associated with emotional, learning and memory processes; being particularly vulnerable to stress. Exposure to stressful stimuli leads to...

Sensory deprivation leading to late onset psychosis

Journal of Geriatric Mental Health December 18, 2017 Swapnajeet Sahoo, Sandeep Grover

Sensory deprivation is understood as diminution or absence of perceptual experiences to the usual external stimuli. Sensory deprivation in elderly is reported to be associated with depression, anxiety, psychosis, dementia, etc. In this report, we present the case of an 84-year- elderly man who developed auditory hallucination and after 1 year of onset of hearing difficulties. He was managed...

DOI: 10.4103/2348-9995.195676 (opens in new tab) Full text (opens in new tab) Auditory hallucinations Hearing impairment Sensory deprivation

[Contributions and challenges associated with bodily practices and meditation for health promotion in the public primary care system in the city of São Paulo, Brazil].

Cadernos de Saúde Pública December 18, 2017 Ana Tereza Costa Galvanese, Nelson Filice de Barros, Ana Flávia Pires Lucas d'Oliveira

The article presents an analysis of contributions and challenges associated with bodily practices and meditation for health promotion in the public primary care system. The qualitative study was developed in 16 healthcare units in the city of São Paulo, Brazil, using interviews with 29 health professionals and 36 practitioners of bodily practices and meditation, including participant...

DOI: 10.1590/0102-311x00122016 (opens in new tab) Full text (opens in new tab) Meditation Humans Treatment outcome Reproducibility of results +9